Header Logo

Connection

EVELINE BARBIERI to Proto-Oncogene Proteins c-mdm2

Back to Details
This is a "connection" page, showing publications EVELINE BARBIERI has written about Proto-Oncogene Proteins c-mdm2.
EVELINE BARBIERI
Connection Strength
1.017
Proto-Oncogene Proteins c-mdm2
  1. p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy. Clin Cancer Res. 2017 Nov 01; 23(21):6629-6639.
    View in: PubMed
    Score: 0.518
  2. MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death. Mol Cancer Ther. 2006 Sep; 5(9):2358-65.
    View in: PubMed
    Score: 0.242
  3. A p53 drug response signature identifies prognostic genes in high-risk neuroblastoma. PLoS One. 2013; 8(11):e79843.
    View in: PubMed
    Score: 0.100
  4. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma. Angiogenesis. 2011 Sep; 14(3):255-66.
    View in: PubMed
    Score: 0.083
  5. Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivo. Neoplasia. 2009 Aug; 11(8):753-62.
    View in: PubMed
    Score: 0.074
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.